Antidepressant-like responses in the forced swimming test elicited by glutathione and redox modulation

Behavioural Brain Research

Volumn 253, Issue , 2013, Pages 165-172

  Rosa, Juliana M ^a,b   Dafre, Alcir Luiz ^a   Rodrigues, Ana Lúcia S ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

Antidepressant; Depressive disorders; Forced swimming test; Gamma glutamyl transpeptidase; Glutathione; Redox regulation

Indexed keywords

ANTIDEPRESSANT AGENT; GLUTATHIONE;

ANIMAL BEHAVIOR; ARTICLE; BEHAVIOR CHANGE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; EXPERIMENTAL TEST; FORCED SWIMMING TEST; GLUTATHIONE METABOLISM; IMMOBILIZATION; NEUROMODULATION; NEUROPROTECTION; OXIDATION REDUCTION STATE; PREDICTION; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN DEGRADATION; TAIL SUSPENSION TEST;

5,5′-DITHIOBIS(2-NITROBENZOIC ACID); ANTIDEPRESSANT; BSO; DEPRESSIVE DISORDERS; DL-DITHIOTHREITOL; DTNB; DTT; FORCED SWIMMING TEST; FST; GAMMA-GLUTAMYL TRANSPEPTIDASE; GCL; GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE-S-TRANSFERASE; GPX; GR; GSH-T; GST; L-BUTHIONINE-[S,R]-SULFOXIMINE; REDOX REGULATION; TAIL SUSPENSION TEST; TOTAL GLUTATHIONE (GSH PLUS GSSG IN GSH-EQUIVALENTS); TST; Γ-GLUTAMYL TRANSPEPTIDASE; Γ-GT;

ANIMALS; ANTIDEPRESSIVE AGENTS; ANTIMETABOLITES; ANTIOXIDANTS; BUTHIONINE SULFOXIMINE; DEPRESSION; DITHIONITROBENZOIC ACID; DITHIOTHREITOL; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; HINDLIMB SUSPENSION; INJECTIONS, INTRAVENTRICULAR; MALE; MICE; MOTOR ACTIVITY; OXIDATION-REDUCTION; SWIMMING;

EID: 84881107079     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2013.07.009     Document Type: Article

References (72)

1. Dringen R., Pawlowski P.G., Hirrlinger J. Peroxide detoxification by brain cells. Journal of Neuroscience Research 2005, 79:157-165.
2. Lewerenz J., Hewett S.J., Huang Y., Lambros M., Gout P.W., Kalivas P.W., et al. The cystine/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities. Antioxidants & Redox Signaling 2013, 18:522-555.
3. Anathy V., Roberson E.C., Guala A.S., Godburn K.E., Budd R.C., Janssen-Heininger Y.M.W. Redox-based regulation of apoptosis: S-glutathionylation as a regulatory mechanism to control cell death. Antioxidants & Redox Signaling 2012, 16:496-505.
4. Haddad J.J., Harb H.L. l-Gamma-glutamyl-l-cysteinyl-glycine (glutathione; GSH) and GSH-related enzymes in the regulation of pro- and anti-inflammatory cytokines: a signaling transcriptional scenario for redox(y) immunologic sensor(s)?. Molecular Immunology 2005, 42:987-1014.
5. Hirrlinger J., Dringen R. The cytosolic redox state of astrocytes: maintenance, regulation and functional implications for metabolite trafficking. Brain Research Reviews 2010, 63:177-188.
6. Lu S.C. Regulation of glutathione synthesis. Molecular Aspects of Medicine 2009, 30:42-59.
7. Orlowski M., Meister A. The gamma-glutamyl cycle: a possible transport system for amino acids. Proceedings of the National Academy of Sciences of the United States of America 1970, 67:1248-1255.
8. Griffith O.W., Meister A. Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine). Journal of Biological Chemistry 1979, 254:7558-7560.
9. Kulak A., Cuenod M., Do K.Q. Behavioral phenotyping of glutathione-deficient mice: relevance to schizophrenia and bipolar disorder. Behavioural Brain Research 2012, 226:563-570.
10. Yoshiba-Suzuki S., Sagara J., Bannai S., Makino N. The dynamics of cysteine, glutathione and their disulphides in astrocyte culture medium. Journal of Biochemistry 2011, 150:95-102.
11. Lantum H.B.M., Iyer R.A., Anders M.W. Acivicin-induced alterations in renal and hepatic glutathione concentrations and in gamma-glutamyltransferase activities. Biochemical Pharmacology 2004, 67:1421-1426.
12. Garcia-Garcia A., Zavala-Flores L., Rodriguez-Rocha H., Franco R. Thiol-redox signaling, dopaminergic cell death, and Parkinson's disease. Antioxidants & Redox Signaling 2012, 17:1764-1784.
13. Pocernich C.B., Butterfield D.A. Elevation of glutathione as a therapeutic strategy in Alzheimer disease. Biochimica et Biophysica Acta: Molecular Basis of Disease 2012, 1822:625-630.
14. Do K.Q., Trabesinger A.H., Kirsten-Krüger M., Lauer C.J., Dydak U., Hell D., et al. Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo. European Journal of Neuroscience 2000, 12:3721-3728.
15. Gawryluk J.W., Wang J.-F., Andreazza A.C., Shao L., Young L.T. Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders. International Journal of Neuropsychopharmacology 2011, 14:123-130.
16. Abe K., Nakanishi K., Saito H. The possible role of endogenous glutathione as an anticonvulsant in mice. Brain Research 2000, 854:235-238.
17. Fernandez-Fernandez S., Almeida A., Bolaños J.P. Antioxidant and bioenergetic coupling between neurons and astrocytes. Biochemical Journal 2012, 443:3-11.
18. Maes M., Galecki P., Chang Y.S., Berk M. A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2011, 35:676-692.
19. Lauterbach E.C., Shillcutt S.D., Victoroff J., Coburn K.L., Mendez M.F. Psychopharmacological neuroprotection in neurodegenerative disease: heuristic clinical applications. Journal of Neuropsychiatry and Clinical Neurosciences 2010, 22:130-154.
20. Freitas A.E., Machado D.G., Budni J., Neis V.B., Balen G.O., Lopes M.W., et al. Fluoxetine modulates hippocampal cell signaling pathways implicated in neuroplasticity in olfactory bulbectomized mice. Behavioural Brain Research 2013, 237:176-184.
21. Leonard B., Maes M. Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression. Neuroscience and Biobehavioral Reviews 2012, 36:764-785.
22. Berk M., Copolov D.L., Dean O., Lu K., Jeavons S., Schapkaitz I., et al. N-acetyl cysteine for depressive symptoms in bipolar disorder-a double-blind randomized placebo-controlled trial. Biological Psychiatry 2008, 64:468-475.
23. Moretti M., Colla A., de Oliveira Balen G., dos Santos D.B., Budni J., de Freitas A.E., et al. Ascorbic acid treatment, similarly to fluoxetine, reverses depressive-like behavior and brain oxidative damage induced by chronic unpredictable stress. Journal of Psychiatric Research 2012, 46:331-340.
24. Shieh C.-H., Hong C.-J., Huang Y.-H., Tsai S.-J. Potential antidepressant properties of cysteamine on hippocampal BDNF levels and behavioral despair in mice. Progress in Neuro-psychopharmacology & Biological Psychiatry 2008, 32:1590-1594.
25. Kutiyanawalla A., Terry A.V., Pillai A. Cysteamine attenuates the decreases in TrkB protein levels and the anxiety/depression-like behaviors in mice induced by corticosterone treatment. PLoS ONE 2011, 6:e26153.
26. Lobato K.R., Cardoso C.C., Binfaré R.W., Budni J., Wagner C.L.R., Brocardo P.S., et al. α-Tocopherol administration produces an antidepressant-like effect in predictive animal models of depression. Behavioural Brain Research 2010, 209:249-259.
27. Kulak A., Steullet P., Cabungcal J.-H., Werge T., Ingason A., Cuenod M., et al. Redox dysregulation in the pathophysiology of schizophrenia and bipolar disorder: insights from animal models. Antioxidants & Redox Signaling 2013, 18:1428-1443.
28. Thornalley P.J. Protein and nucleotide damage by glyoxal and methylglyoxal in physiological systems-role in ageing and disease. Drug Metabolism and Drug Interactions 2008, 23:125-150.
29. Xue M., Rabbani N., Thornalley P.J. Glyoxalase in ageing. Seminars in Cell & Developmental Biology 2011, 22:293-301.
30. Distler M.G., Palmer A.A. Role of glyoxalase 1 (Glo1) and methylglyoxal (MG) in behavior: recent advances and mechanistic insights. Frontiers in Genetics 2012, 3:250.
31. Porsolt R.D., Bertin A., Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Archives Internationales de Pharmacodynamie et de Therapie 1977, 229:327-336.
32. Steru L., Chermat R., Thierry B., Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 1985, 85:367-370.
33. Laursen S.E., Belknap J.K. Intracerebroventricular injections in mice. Some methodological refinements. Journal of Pharmacological Methods 1986, 16:355-357.
34. Franklin K.B.J., Paxinos G. The Mouse Brain in Stereotaxic Coordinates 1997, Academic Press, San Diego.
35. Cunha M.P., Pazini F.L., Oliveira A., Bettio L.E.B., Rosa J.M., Machado D.G., et al. The activation of α1-adrenoceptors is implicated in the antidepressant-like effect of creatine in the tail suspension test. Progress in Neuro-psychopharmacology & Biological Psychiatry 2013, 44C:39-50.
36. Rodrigues A.L., Rocha J.B., Mello C.F., Souza D.O. Effect of perinatal lead exposure on rat behaviour in open-field and two-way avoidance tasks. Pharmacology & Toxicology 1996, 79:150-156.
37. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Analytical Biochemistry 1969, 27:502-522.
38. Akerboom T.P., Sies H. Assay of glutathione, glutathione disulfide, and glutathione mixed disulfides in biological samples. Methods in Enzymology 1981, 77:373-382.
39. Wendel A. Glutathione peroxidase. Methods in Enzymology 1981, 77:325-333.
40. Habig W.H., Jakoby W.B. Assays for differentiation of glutathione S-transferases. Methods in Enzymology 1981, 77:398-405.
41. Carlberg I., Mannervik B. Glutathione reductase. Methods in Enzymology 1985, 113:484-490.
42. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 1976, 72:248-254.
43. Cryan J.F., Markou A., Lucki I. Assessing antidepressant activity in rodents: recent developments and future needs. Trends in Pharmacological Sciences 2002, 23:238-245.
44. Willner P. Animal models of depression: validity and applications. Advances in Biochemical Psychopharmacology 1995, 49:19-41.
45. Madrigal J.L., Olivenza R., Moro M.A., Lizasoain I., Lorenzo P., Rodrigo J., et al. Glutathione depletion, lipid peroxidation and mitochondrial dysfunction are induced by chronic stress in rat brain. Neuropsychopharmacology 2001, 24:420-429.
46. Sahin E., Gümüşlü S. Alterations in brain antioxidant status, protein oxidation and lipid peroxidation in response to different stress models. Behavioural Brain Research 2004, 155:241-248.
47. García-Bueno B., Madrigal J.L.M., Lizasoain I., Moro M.A., Lorenzo P., Leza J.C. Peroxisome proliferator-activated receptor gamma activation decreases neuroinflammation in brain after stress in rats. Biological Psychiatry 2005, 57:885-894.
48. Pal S.N., Dandiya P.C. Glutathione as a cerebral substrate in depressive behavior. Pharmacology Biochemistry and Behavior 1994, 48:845-851.
49. Altschule M.D., Goncz R.M., Henneman D.H., Holliday P.D. Carbohydrate metabolism in brain disease. VII. The effect of glutathione on carbohydrate intermediary metabolism in schizophrenic and manic-depressive psychoses. AMA Archives of Internal Medicine 1957, 99:22-27.
50. Shao L., Cui J., Young L.T., Wang J.-F. The effect of mood stabilizer lithium on expression and activity of glutathione S-transferase isoenzymes. Neuroscience 2008, 151:518-524.
51. Krömer S.A., Kessler M.S., Milfay D., Birg I.N., Bunck M., Czibere L., et al. Identification of glyoxalase-I as a protein marker in a mouse model of extremes in trait anxiety. Journal of Neuroscience 2005, 25:4375-4384.
52. Ditzen C., Jastorff A.M., Kessler M.S., Bunck M., Teplytska L., Erhardt A., et al. Protein biomarkers in a mouse model of extremes in trait anxiety. Molecular & Cellular Proteomics 2006, 5:1914-1920.
53. Hovatta I., Tennant R.S., Helton R., Marr R.A., Singer O., Redwine J.M., et al. Glyoxalase 1 and glutathione reductase 1 regulate anxiety in mice. Nature 2005, 438:662-666.
54. Hovatta I., Juhila J., Donner J. Oxidative stress in anxiety and comorbid disorders. Neuroscience Research 2010, 68:261-275.
55. Cacciatore I., Cornacchia C., Pinnen F., Mollica A., Di Stefano A. Prodrug approach for increasing cellular glutathione levels. Molecules 2010, 15:1242-1264.
56. Wheeler G.L., Trotter E.W., Dawes I.W., Grant C.M. Coupling of the transcriptional regulation of glutathione biosynthesis to the availability of glutathione and methionine via the Met4 and Yap1 transcription factors. Journal of Biological Chemistry 2003, 278:49920-49928.
57. Aoyama K., Watabe M., Nakaki T. Regulation of neuronal glutathione synthesis. Journal of Pharmacological Sciences 2008, 108:227-238.
58. Varga V., Janáky R., Oja S.S. Modulation of glutamate agonist-induced influx of calcium into neurons by gamma-l-glutamyl and beta-l-aspartyl dipeptides. Neuroscience Letters 1992, 138:270-274.
59. Janáky R., Ogita K., Pasqualotto B.A., Bains J.S., Oja S.S., Yoneda Y., et al. Glutathione and signal transduction in the mammalian CNS. Journal of Neurochemistry 1999, 73:889-902.
60. Lipton S.A., Choi Y.-B., Takahashi H., Zhang D., Li W., Godzik A., et al. Cysteine regulation of protein function-as exemplified by NMDA-receptor modulation. Trends in Neurosciences 2002, 25:474-480.
61. Pompella A., Visvikis A., Paolicchi A., De Tata V., Casini A.F. The changing faces of glutathione, a cellular protagonist. Biochemical Pharmacology 2003, 66:1499-1503.
62. Paolicchi A., Dominici S., Pieri L., Maellaro E., Pompella A. Glutathione catabolism as a signaling mechanism. Biochemical Pharmacology 2002, 64:1027-1035.
63. 2-induced apoptosis and expression of catalase. Toxicology in Vitro 2013, 27:991.
64. Amato A., Connolly C.N., Moss S.J., Smart T.G. Modulation of neuronal and recombinant GABAA receptors by redox reagents. Journal of Physiology 1999, 517(Pt. 1):35-50.
65. Carai M.A.M., Vacca G., Serra S., Colombo G., Froestl W., Gessa G.L. Suppression of GABA(B) receptor function in vivo by disulfide reducing agent, dl-dithiothreitol (DTT). Psychopharmacology 2004, 174:283-290.
66. Fratelli M., Goodwin L.O., Ørom U.A., Lombardi S., Tonelli R., Mengozzi M., et al. Gene expression profiling reveals a signaling role of glutathione in redox regulation. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:13998-14003.
67. Canini F., Bréjot T., d'Aléo P., Mercier S., Bourdon L. NMDA receptors are involved in dithiothreitol-induced hypothermia. European Journal of Pharmacology 2001, 426:179-183.
68. Calero C.I., Vickers E., Moraga Cid G., Aguayo L.G., von Gersdorff H., Calvo D.J. Allosteric modulation of retinal GABA receptors by ascorbic acid. Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2011, 31:9672-9682.
69. Go Y.-M., Jones D.P. Cysteine/cystine redox signaling in cardiovascular disease. Free Radical Biology & Medicine 2011, 50:495-509.
70. Blanquicett C., Kang B.-Y., Ritzenthaler J.D., Jones D.P., Hart C.M. Oxidative stress modulates PPAR gamma in vascular endothelial cells. Free Radical Biology & Medicine 2010, 48:1618-1625.
71. Zheng M.-Q., Tang K., Zimmerman M.C., Liu L., Xie B., Rozanski G.J. Role of gamma-glutamyl transpeptidase in redox regulation of K+ channel remodeling in postmyocardial infarction rat hearts. American Journal of Physiology: Cell Physiology 2009, 297:C253-C262.
72. Conrad M., Sato H. The oxidative stress-inducible cystine/glutamate antiporter, system x (c) (-): cystine supplier and beyond. Amino Acids 2012, 42:231-246.